assubex 2,5 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
onureg
bristol-myers squibb pharma eeig - azacitidín - leukémia, myeloidná, akútna - antineoplastické činidlá - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
xiltess 20 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
xiltess 15 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
xiltess 10 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
xiltess 2,5 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
rivaroxaban stada 15 mg tvrdé kapsuly
stada arzneimittel ag, nemecko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
rivaroxaban stada 15 mg tvrdé kapsuly + rivaroxaban stada 20 mg tvrdé kapsuly
stada arzneimittel ag, nemecko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
rivaroxaban stada 20 mg tvrdé kapsuly
stada arzneimittel ag, nemecko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
enkia 20 mg filmom obalené tablety
medochemie ltd., cyprus - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)